| dc.description.abstract | Supply chain management includes a number of linked processes that begin with the
acquisition of raw materials, continue through their transformation into finished products,
and end with the effective distribution of the finished products to customers via distribution
networks. The supply chain of a pharmaceutical company involves forecasting,
procurement, logistics, operations, inventory management, transportation, warehouse,
distribution, customer service etc. However, it is not easy to develop a standard model of
supply chain management in a business organization.
Delta Pharma Ltd. is a reputed pharmaceutical company of Bangladesh and stands out as a
prominent producer and exporter of pharmaceutical products. The report includes
assessment of the supply chain management system of Delta Pharma Ltd. This assessment
will help the organization to develop an effective supply chain management system to
obtain better performance, customer satisfaction, product quality, supplier performance,
material flow integration, manufacturing machinery efficiency, and information
management. The analysis will help the business to improve its plans, which eventually
helps it achieve an enhanced competitive advantage. The objective of this study is to assess
the extent to which the supply chain of NJPL functions; to understand it’s supply chain
management; to identify the barriers and challenges of the NJPL supply chain; to make
recommendations for overcoming the challenges and to improve supply chain management
system.
In a highly competitive and regulated business, an efficient supply chain management
system is essential to its success. Quality control, inventory control and cost effectiveness
are the strengths of the DPL supply chain system which results in customer satisfaction
and risk reduction. The pharmaceutical sector is a heavily regulated sector and it can be
difficult to comply with many regulatory standards, such as Good Manufacturing Practices
(GMP), Good Distribution Practices (GDP), and other national and international laws.
Contamination, fake goods, temperature-sensitive goods, forecast errors etc.
May cause supply chain interruptions of DPL and may decrease the efficiency of the supply
chain system. The resilience, effectiveness, and sustainability of Delta Pharma Ltd supply
chain may be improved by tackling the challenges and putting the suggested measures into
practice. This will put the business in a better position to adapt to changing market
conditions, boost customer happiness, and guarantee the company's long-term
development and profitability. | en_US |
